(3R,4S) -Tofacitinib
(3R,4S) -Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib inhibits JAK3 with IC50 of 1 nM.
Product Specifications
CAS Number
[1092578-46-5]
UNSPSC
12352005
Hazard Statement
H302-H360
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/_3R,4S_-Tofacitinib.html
Purity
99.88
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN(C1=NC=NC2=C1C=CN2)[C@@H]3[C@@H](C)CCN(C(CC#N)=O)C3
Molecular Formula
C16H20N6O
Molecular Weight
312.37
Precautions
P264-P270-P280-P330-P405-P501
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1232939-01 0.02 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Probable ribokinase (RBK1)
Ask
View Details MBS1232939-02 0.02 mg (Yeast)
Recombinant Saccharomyces cerevisiae Probable ribokinase (RBK1)
Ask
View Details 
MBS1232939-03 0.1 mg (E-Coli)
Recombinant Saccharomyces cerevisiae Probable ribokinase (RBK1)
Ask
View Details 
MBS1232939-04 0.1 mg (Yeast)
Recombinant Saccharomyces cerevisiae Probable ribokinase (RBK1)
Ask
View Details 
MBS1232939-05 0.02 mg (Baculovirus)
Recombinant Saccharomyces cerevisiae Probable ribokinase (RBK1)
Ask
View Details MBS1232939-06 0.02 mg (Mammalian-Cell)
Recombinant Saccharomyces cerevisiae Probable ribokinase (RBK1)
Ask
View Details